Manufacturer
Será en Octubre
- Desde
- 25 Sep 2012
- Mensajes
- 18.176
- Reputación
- 71.777
Desplomes y fin en tiempo real. Veréis en 15 días.
*Tema mítico* : ⚡⚡(HILO OFICIAL) : CRISIS DEL cobi19 ☣SARS-CoV2☣
- Autor del tema ULTRAPACO
- Fecha de inicio
hornblower
Madmaxista
- Desde
- 5 Dic 2009
- Mensajes
- 1.756
- Reputación
- 5.293
Soy de los que sigue y participa en el hilo desde enero y pienso diferente,
pienso que los chinos fueron transparentes con la OMS, te pongo en spoiler un documento que guardé el 27 de enero con la info que ya tenía la OMS con la visita que hicieron a China sus inspectores y los de la CDC americana. Es un documento que vale horo, el documento y todos los links que contiene. En él ya se indica qeu se transmite de persona a persona, periodo de incubación de 2 a 14 días, 25% de casos son graves, transmisión por aerosoles, mortalidad del 3%.
Expert guidance and commentary
Key facts for clinicians
By Margaret Trexler Hessen, MD | January 27, 2020
Background: In December, China notified the World Health Organization of several cases of human respiratory illness, which appeared to be linked to an open seafood and livestock market in the city of Wuhan↗. The infecting agent has since been identified as a novel cobi19↗, now called 2019-nCoV. Although the bichito is presumed zoonotic in origin, person-to-person spread is evident. Cases have now been reported in many other areas of China and in other countries in Asia, Europe, the Asia Pacific and North America. Although travel within China has been restricted, and screening of travelers is being implemented in other countries, it is anticipated that more cases will be seen both inside China and internationally.
Novel coronaviruses have emerged as human pathogens in the past, notably associated with outbreaks of SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome). Current investigative methods and recommendations↗ derive in some part from the experience of those epidemics.
Clinical presentation: The incubation period is thought to be 2 to 14 days↗. Symptoms include fever (which may be absent in persons at extremes of age or with immunocompromise), cough and dyspnea. Chest radiographs may show bilateral infiltrates. Clinical illness varies from mild to severe; about 25% of confirmed cases have been classified as severe, and there are increasing numbers of deaths↗. In early cases, mortality was associated with advanced age or comorbidities.
Diagnosis: Although respiratory infections (including influenza) are prevalent in the northern hemisphere during the winter, clinicians should inquire about travel history in persons presenting with respiratory illness. The possibility of 2019-nCoV infection should be suspected in persons who present with compatible clinical illness and exposure history. The US Centers for Disease Control (CDC)↗ and World Health Organization (WHO) have slightly different criteria for whom to test, as noted below:
•Recent travel (within 14 days) from Wuhan, Hubei Province, China (WHO, CDC).
•Close contact with a person suspected or known to have infection due to 2019-nCoV (WHO, CDC). The CDC defines close contact as being within 6 feet (2 meters) or within a room or care area for a prolonged period without personal protective equipment OR having direct contact with secretions of a person with 2019-nCoV infection.
•Exposure to a healthcare facility in a country where hospital-associated nCoV infections have been reported (WHO).
•The disease occurs in a healthcare worker who has been working in an environment where patients with severe acute respiratory infections are being cared for, without regard to place of residence or history of travel (WHO).
•The person develops an unusual or unexpected clinical course, especially sudden deterioration despite appropriate treatment, without regard to place of residence or history of travel, even if another etiology has been identified that fully explains the clinical presentation (WHO).
In the United States, suspected cases should be reported immediately to local or state health departments, which will determine whether the patient meets clinical and epidemiologic criteria for disease and coordinate diagnostic testing of suspected patients through the CDC. Collection of specimens from the upper respiratory tract, lower respiratory tract and serum is recommended as a priority; other specimens, such as stool or urine, may be collected and stored to be tested at the discretion of the CDC. The CDC provides detailed information on collection and shipping of specimens↗ for cases approved by local or state authorities. The CDC advised that testing for other respiratory pathogens by the provider should be done as part of the initial evaluation and should not delay specimen shipping to CDC.
If a patient with suspected 2019-nCoV infection tests positive for another respiratory pathogen, after clinical evaluation and consultation with public health authorities, they may no longer be considered a person under investigation.
Management: No specific antiviral agent is available for treatment of this infection, and there is no vaccine. Treatment is supportive and includes supplemental oxygen and conservative fluid management↗, as indicated by clinical condition. WHO provides detailed guidance on such supportive measures and cautions↗ that severely ill patients should be treated empirically for other possible causes while diagnostic test results are pending.
Infection control measures↗ are an integral part of management. Precautions should be instituted as soon as 2019-nCoV infection is suspected↗:
•Provide the patient with a face mask and place the patient in a closed room (preferably with structural safeguards against airborne transmission).
•Persons entering the room should ***ow standard, contact, and airborne precautions↗.
•Patients managed at home are encouraged to self-isolate to a single area of the house (preferably with a separate bathroom) and to wear a face mask during any contact with household members.
•The patient and all household members should ***ow diligent hand and cough hygiene↗.
Complications: Respiratory failure and septic shock occur in some patients. The mortality rate is about 3 percent↗.
Margaret Trexler Hessen, MD, is an infectious disease specialist with 20 years of clinical practice experience and public health service, including outbreak management. She has been with Elsevier since 2010 and is currently Director, Point of Care.
Key facts for clinicians
By Margaret Trexler Hessen, MD | January 27, 2020
Background: In December, China notified the World Health Organization of several cases of human respiratory illness, which appeared to be linked to an open seafood and livestock market in the city of Wuhan↗. The infecting agent has since been identified as a novel cobi19↗, now called 2019-nCoV. Although the bichito is presumed zoonotic in origin, person-to-person spread is evident. Cases have now been reported in many other areas of China and in other countries in Asia, Europe, the Asia Pacific and North America. Although travel within China has been restricted, and screening of travelers is being implemented in other countries, it is anticipated that more cases will be seen both inside China and internationally.
Novel coronaviruses have emerged as human pathogens in the past, notably associated with outbreaks of SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome). Current investigative methods and recommendations↗ derive in some part from the experience of those epidemics.
Clinical presentation: The incubation period is thought to be 2 to 14 days↗. Symptoms include fever (which may be absent in persons at extremes of age or with immunocompromise), cough and dyspnea. Chest radiographs may show bilateral infiltrates. Clinical illness varies from mild to severe; about 25% of confirmed cases have been classified as severe, and there are increasing numbers of deaths↗. In early cases, mortality was associated with advanced age or comorbidities.
Diagnosis: Although respiratory infections (including influenza) are prevalent in the northern hemisphere during the winter, clinicians should inquire about travel history in persons presenting with respiratory illness. The possibility of 2019-nCoV infection should be suspected in persons who present with compatible clinical illness and exposure history. The US Centers for Disease Control (CDC)↗ and World Health Organization (WHO) have slightly different criteria for whom to test, as noted below:
•Recent travel (within 14 days) from Wuhan, Hubei Province, China (WHO, CDC).
•Close contact with a person suspected or known to have infection due to 2019-nCoV (WHO, CDC). The CDC defines close contact as being within 6 feet (2 meters) or within a room or care area for a prolonged period without personal protective equipment OR having direct contact with secretions of a person with 2019-nCoV infection.
•Exposure to a healthcare facility in a country where hospital-associated nCoV infections have been reported (WHO).
•The disease occurs in a healthcare worker who has been working in an environment where patients with severe acute respiratory infections are being cared for, without regard to place of residence or history of travel (WHO).
•The person develops an unusual or unexpected clinical course, especially sudden deterioration despite appropriate treatment, without regard to place of residence or history of travel, even if another etiology has been identified that fully explains the clinical presentation (WHO).
In the United States, suspected cases should be reported immediately to local or state health departments, which will determine whether the patient meets clinical and epidemiologic criteria for disease and coordinate diagnostic testing of suspected patients through the CDC. Collection of specimens from the upper respiratory tract, lower respiratory tract and serum is recommended as a priority; other specimens, such as stool or urine, may be collected and stored to be tested at the discretion of the CDC. The CDC provides detailed information on collection and shipping of specimens↗ for cases approved by local or state authorities. The CDC advised that testing for other respiratory pathogens by the provider should be done as part of the initial evaluation and should not delay specimen shipping to CDC.
If a patient with suspected 2019-nCoV infection tests positive for another respiratory pathogen, after clinical evaluation and consultation with public health authorities, they may no longer be considered a person under investigation.
Management: No specific antiviral agent is available for treatment of this infection, and there is no vaccine. Treatment is supportive and includes supplemental oxygen and conservative fluid management↗, as indicated by clinical condition. WHO provides detailed guidance on such supportive measures and cautions↗ that severely ill patients should be treated empirically for other possible causes while diagnostic test results are pending.
Infection control measures↗ are an integral part of management. Precautions should be instituted as soon as 2019-nCoV infection is suspected↗:
•Provide the patient with a face mask and place the patient in a closed room (preferably with structural safeguards against airborne transmission).
•Persons entering the room should ***ow standard, contact, and airborne precautions↗.
•Patients managed at home are encouraged to self-isolate to a single area of the house (preferably with a separate bathroom) and to wear a face mask during any contact with household members.
•The patient and all household members should ***ow diligent hand and cough hygiene↗.
Complications: Respiratory failure and septic shock occur in some patients. The mortality rate is about 3 percent↗.
Margaret Trexler Hessen, MD, is an infectious disease specialist with 20 years of clinical practice experience and public health service, including outbreak management. She has been with Elsevier since 2010 and is currently Director, Point of Care.
Acerca de la secuenciación del genoma este hilo es muy ilustrativo. En él se cuenta que realmente se envió el día 5 de enero a Genbank aunque no fue hasta el día 10 de enero hasta que esta base de datos lo hizo público. La falta de reacción inicial no fue sólo china.
Acerca de la OMS, pienso que quien realmente la cagó fueron los mandos intermedios que dieron más importancia a la economía, y aquí tenemos el más claro ejemplo con María Neira, un personaje nefasto cuya mayor preocupación era no alarmar. En el resto de Europa parecido, pero luego escuchabas a Mike Ryan, el director ejecutivo de la OMS y decía verdades como puños pero no se le daba eco.
No olvidemos que la OMS es un instrumento supranacional y que no podía dar indicaciones país por país. En el tema de las mascaras creo que se vio sobrepasado por la evidencia de que los gobiernos habían mentido a la población acerca de la importancia de las mascaras simplemente por el hecho de que no las tenían. Pero fue una cagada grande sin duda.
Estoseacaba
Madmaxista
- Desde
- 12 Ene 2010
- Mensajes
- 1.658
- Reputación
- 9.028
Debo poner un pero a su análisis... Hoy es día 30. Por lo demás, 100% de acuerdo. Y reitero mi agradecimiento por la información diaria que trae al foro.
Portador del Caos
Madmaxista
- Desde
- 27 Jun 2007
- Mensajes
- 2.551
- Reputación
- 18.426
Gracias.
Sí, pongo la fecha que indica la web oficial ahora: "Situació a 29/10/2020", y es la que acabo poniendo en el informe pa no liarla. Imagino que como sacan los datos "temprano", de hoy todavía no tienen datos. En otras CCAA no se como se lo montan, la verdad. (Si son datos de ayer o un mix)
Estoseacaba
Madmaxista
- Desde
- 12 Ene 2010
- Mensajes
- 1.658
- Reputación
- 9.028
Ah, ok! No me había fijado hasta hoy. Perfecto, pues.
montytorri
Madmaxista
- Desde
- 5 Mar 2011
- Mensajes
- 12.042
- Reputación
- 40.506
Hay 3 filtros en rentas, según el importe a devolver jeje. No, no curro en aeat
SatanClaus
Madmaxista
- Desde
- 15 Feb 2010
- Mensajes
- 1.355
- Reputación
- 7.993
Buena demostración, Manufacturer. esa época en el 2020 de la que yo le hablo coronatimo desmontada. Para rematar, yo añadiría esta:
Incidencia del efecto Casimir en los mercados de leguminosas de Asia Central
En 36,21 días sí que lo vais a flipar todos.
Burbujarras
Carretas
- Desde
- 17 Abr 2019
- Mensajes
- 4.397
- Reputación
- 2.669
jorobar más batillas en labos, cuando ven que el papaya cudeira da negatifo, metiendo en el windows sopas de genes de esputos de ventiladores mecánicos que positivizen sintomatología moribunda, lo que faltaba.
Carpanteria
Himbersor
- Desde
- 10 Abr 2020
- Mensajes
- 408
- Reputación
- 667
Pero no contagiaban solo los bares y los botellones? Como va a ser que ahora hay casos si todo el mundo lleva cubreboca y el ocio esta cerrado jajaja.
A seguir restringiendo derechos para nada.
No se podía saber...
Abner
Madmaxista
- Desde
- 17 May 2010
- Mensajes
- 3.208
- Reputación
- 6.466
En el informe diario de la ccaa de Madrid, se ponen datos por la tarde de ese día, así que imagino que no pueden ser completos....
Enviado desde mi Mi A2 mediante Tapatalk
Snowball
Será en Octubre
- Desde
- 8 Sep 2007
- Mensajes
- 24.209
- Reputación
- 79.515
Pero si hasta hace unos dias la OMS seguia negando la transmision por aerosoles, junto con nuestro ejperto Simon
Cuando hay informes e investigaciones desde Marzo, incluso del propio CDC Chino, avisando de la transmision aérea. Pero claro una cosa es lo que digan los científicos, y otra el Gobierno Chino...
Que haya habido técnicos, como el informe que posteas, que sean profesionales no lo niego. Pero el organismo en si, que el que tiene que dar la directiva final para que el resto de paises toman las medidas oportunas, ha sido totalmente negligente.
¿Negligencia o intereses ocultos?
Y respecto a China, lo siento pero sigo sin creerme los 4000 muertos. 4000 chinos deben de morir todos los dias solamente en accidentes laborales. Cualquier con 2 dedos de frente sabe que una dictadura y la segunda económia del mundo no paraliza el pais por esa cantidad de muertos.
For a month, the Chinese Communist Party, instead of fighting the contagion, did everything possible to censor all information about the el bichito-19 outbreak. After President Xi Jinping declared "a people's war" on the epidemic on January 20, Chinese security services pursued 5,111 cases of "fabricating and deliberately disseminating false and harmful information". The Chinese Human Rights Defenders documented several types of punishment, including detention, disappearance, fines, interrogations, forced confessions and "educational reprimand".
After that, China lied about the real number of deaths. There are photographs of long lines of stacked urns greeting family members of the dead at funeral homes in Wuhan. Outside one funeral home, trucks shipped in 2,500 urns. According to Chinese official figures, 2,548 people in Wuhan have died of the el bichito-19. According to an analysis by Radio Free Asia, seven funeral homes in Wuhan were each handing out 500 funeral urns containing remains for 12 days, from March 23 to the traditional tomb-sweeping festival of April 5, a time that would indicate up to 42,000 urns, or ten times higher than the official figure.
In February, it was reported that Wuhan crematoriums were working around the clock to cope with the massive influx of infected bodies. Wuhan's officials are apparently pushing relatives of the victims to bury the dead "quickly and quietly".
el bichito-19 & China's Colossal Cover-Up
jorobar que no les tiembla el pulso en desplazar a millones de personas de sus hogares para realizar pantanos ,van a sufrir tales daños colaterales por 4000 subditos...
sociedadponzi
never settle
hereje, eso es lejia
me lo dijeron en burbujaOctubrista
Madmaxista
- Desde
- 24 Dic 2018
- Mensajes
- 13.867
- Reputación
- 74.820
Más de 13 000 nuevos casos de el bichito-19 en Chequia el jueves
Los laboratorios en Chequia confirmaron 13 051 casos nuevos de el bichito-19 el jueves. Esta cifra es parecida a la del miércoles, sin embargo, en comparación con el jueves de la semana pasada, el número de casos nuevos se redujo en unos 1100. Los especialistas indican que este índice positivo puede ser resultado del día feriado el miércoles, por la fiesta nacional de la República Checa.
Los epidemiólogos evidencian actualmente a 178 578 personas con el bichito-19. La mayoría tiene síntomas leves, de acuerdo con informaciones publicadas este viernes por el Ministerio de Salud.
Desde el inicio de la epidemia del nuevo cobi19 en Chequia en marzo, los laboratorios evidenciaron a 310 068 contagiados, de los que 128 628 se recuperaron ya de la enfermedad. Sin embargo, aumenta el número de muertos. Hasta el presente fallecieron 2862 personas con el bichito-19, 540 esta semana. El martes fallecieron 159 pacientes, el mayor número hasta el presente.
Hospitalizados con el bichito-19 se encuentran 6604 pacientes, 1500 más que el jueves de la semana pasada. En el caso de 1031 pacientes su estado es grave.
Los laboratorios en Chequia confirmaron 13 051 casos nuevos de el bichito-19 el jueves. Esta cifra es parecida a la del miércoles, sin embargo, en comparación con el jueves de la semana pasada, el número de casos nuevos se redujo en unos 1100. Los especialistas indican que este índice positivo puede ser resultado del día feriado el miércoles, por la fiesta nacional de la República Checa.
Los epidemiólogos evidencian actualmente a 178 578 personas con el bichito-19. La mayoría tiene síntomas leves, de acuerdo con informaciones publicadas este viernes por el Ministerio de Salud.
Desde el inicio de la epidemia del nuevo cobi19 en Chequia en marzo, los laboratorios evidenciaron a 310 068 contagiados, de los que 128 628 se recuperaron ya de la enfermedad. Sin embargo, aumenta el número de muertos. Hasta el presente fallecieron 2862 personas con el bichito-19, 540 esta semana. El martes fallecieron 159 pacientes, el mayor número hasta el presente.
Hospitalizados con el bichito-19 se encuentran 6604 pacientes, 1500 más que el jueves de la semana pasada. En el caso de 1031 pacientes su estado es grave.
Carpanteria
Himbersor
- Desde
- 10 Abr 2020
- Mensajes
- 408
- Reputación
- 667
Fue poner el cubreboca y aumentar los casos que casualidad...